[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Impact of Catheter Ablation in Atrial Fibrillation Among Patients with Heart Failure with Reduced Versus Preserved Ejection Fraction",
    "section": "",
    "text": "Reference Papers:\n\nMunir et al. 2023\nWu et al. 2019\n\nStudy Objective: Assess the impact of Catheter Ablation in Atrial fibrillation among patients with Heart failure with reduced ejection fraction vs preserved ejection fraction.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a primary diagnosis of Atrial fibrillation, comparing those with a secondary diagnosis of HFrEF versus HFpEF.\nHeart failure categories:\n\nHeart failure with reduced ejection fraction\nHeart failure with preserved ejection fraction\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSecondary Outcomes:\n\nAcute Kidney Injury\nAcute Ischemic Stroke\nAcute Myocardial Infarction\nCardiac Tamponade\nCardiac Arrest\nCardiogenic Shock\n\nStatistical Analysis: Multiple logistic and linear regression models to evaluate the independent association of HFrEF vs HFpEF with in-hospital outcomes in patients with AF, adjusting for:\n\nDemographics: Age, sex, race, residential income, insurance, hospital region, hospital bedsize, hospital location, teaching status and admission type (elective or non-elective).\nMedical History: Diabetes mellitus, previous myocardial infarction, hypertension, hyperthyroidism, pulmonary hypertension, chronic obstructive pulmonary disease, alcohol use, obesity, end stage renal disease, obstructive sleep apnea, anemia, previous PCI, previous CABG, previous ICD insertion, previous PPM or CRT insertion, coronary artery disease, previous stroke or TIA, peripheral vascular disease, and valvular heart disease.\nComorbidities: Charlson comorbidity index.\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Impact of Catheter Ablation in Atrial Fibrillation Among Patients with Heart Failure with Reduced Versus Preserved Ejection Fraction",
    "section": "",
    "text": "Reference Papers:\n\nMunir et al. 2023\nWu et al. 2019\n\nStudy Objective: Assess the impact of Catheter Ablation in Atrial fibrillation among patients with Heart failure with reduced ejection fraction vs preserved ejection fraction.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a primary diagnosis of Atrial fibrillation, comparing those with a secondary diagnosis of HFrEF versus HFpEF.\nHeart failure categories:\n\nHeart failure with reduced ejection fraction\nHeart failure with preserved ejection fraction\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSecondary Outcomes:\n\nAcute Kidney Injury\nAcute Ischemic Stroke\nAcute Myocardial Infarction\nCardiac Tamponade\nCardiac Arrest\nCardiogenic Shock\n\nStatistical Analysis: Multiple logistic and linear regression models to evaluate the independent association of HFrEF vs HFpEF with in-hospital outcomes in patients with AF, adjusting for:\n\nDemographics: Age, sex, race, residential income, insurance, hospital region, hospital bedsize, hospital location, teaching status and admission type (elective or non-elective).\nMedical History: Diabetes mellitus, previous myocardial infarction, hypertension, hyperthyroidism, pulmonary hypertension, chronic obstructive pulmonary disease, alcohol use, obesity, end stage renal disease, obstructive sleep apnea, anemia, previous PCI, previous CABG, previous ICD insertion, previous PPM or CRT insertion, coronary artery disease, previous stroke or TIA, peripheral vascular disease, and valvular heart disease.\nComorbidities: Charlson comorbidity index.\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Impact of Catheter Ablation in Atrial Fibrillation Among Patients with Heart Failure with Reduced Versus Preserved Ejection Fraction",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nAtrial fibrillation with heart failure reduced ejection fraction\nN = 18,6851\nAtrial fibrillation with heart failure preserved ejection fraction\nN = 20,6751\np-value2\nOverall\nN = 39,3601\n\n\n\n\nAge, y\n69 (12)\n71 (12)\n&lt;0.001\n70 (12)\n\n\nSex\n\n\n\n\n0.012\n\n\n\n\n    Female\n6,740 (36%)\n8,020 (39%)\n\n\n14,760 (38%)\n\n\n    Male\n11,940 (64%)\n12,655 (61%)\n\n\n24,595 (62%)\n\n\nRace\n\n\n\n\n0.2\n\n\n\n\n    White\n14,145 (77%)\n15,470 (76%)\n\n\n29,615 (77%)\n\n\n    Asian or Pacific Islander\n270 (1.5%)\n255 (1.3%)\n\n\n525 (1.4%)\n\n\n    Black\n2,520 (14%)\n2,850 (14%)\n\n\n5,370 (14%)\n\n\n    Hispanic\n915 (5.0%)\n1,275 (6.3%)\n\n\n2,190 (5.7%)\n\n\n    Native American\n70 (0.4%)\n85 (0.4%)\n\n\n155 (0.4%)\n\n\n    Other\n395 (2.2%)\n385 (1.9%)\n\n\n780 (2.0%)\n\n\nResidential income\n\n\n\n\n0.046\n\n\n\n\n    $1 - $51,999\n4,940 (27%)\n5,850 (29%)\n\n\n10,790 (28%)\n\n\n    $52,000 - $65,999\n5,070 (28%)\n5,310 (26%)\n\n\n10,380 (27%)\n\n\n    $66,000 - $87,999\n4,725 (26%)\n4,835 (24%)\n\n\n9,560 (25%)\n\n\n    $88,000 or more\n3,695 (20%)\n4,310 (21%)\n\n\n8,005 (21%)\n\n\nExpected primary payer\n\n\n\n\n&lt;0.001\n\n\n\n\n    Private\n3,565 (19%)\n2,990 (14%)\n\n\n6,555 (17%)\n\n\n    Medicaid\n1,390 (7.4%)\n1,540 (7.5%)\n\n\n2,930 (7.4%)\n\n\n    Medicare\n13,045 (70%)\n15,255 (74%)\n\n\n28,300 (72%)\n\n\n    Other\n670 (3.6%)\n885 (4.3%)\n\n\n1,555 (4.0%)\n\n\nHospital region\n\n\n\n\n&lt;0.001\n\n\n\n\n    Midwest\n4,600 (25%)\n4,540 (22%)\n\n\n9,140 (23%)\n\n\n    Northeast\n3,910 (21%)\n3,670 (18%)\n\n\n7,580 (19%)\n\n\n    South\n7,785 (42%)\n9,380 (45%)\n\n\n17,165 (44%)\n\n\n    West\n2,390 (13%)\n3,085 (15%)\n\n\n5,475 (14%)\n\n\nHospital bedsize\n\n\n\n\n0.003\n\n\n\n\n    Large\n12,430 (67%)\n12,990 (63%)\n\n\n25,420 (65%)\n\n\n    Medium\n4,455 (24%)\n5,315 (26%)\n\n\n9,770 (25%)\n\n\n    Small\n1,800 (9.6%)\n2,370 (11%)\n\n\n4,170 (11%)\n\n\nHospital location and teaching status\n\n\n\n\n0.4\n\n\n\n\n    Rural\n420 (2.2%)\n505 (2.4%)\n\n\n925 (2.4%)\n\n\n    Urban, non-teaching\n1,740 (9.3%)\n2,150 (10%)\n\n\n3,890 (9.9%)\n\n\n    Urban, teaching\n16,525 (88%)\n18,020 (87%)\n\n\n34,545 (88%)\n\n\nAdmission type\n\n\n\n\n&lt;0.001\n\n\n\n\n    Elective\n5,720 (31%)\n3,495 (17%)\n\n\n9,215 (23%)\n\n\n    Non-elective\n12,950 (69%)\n17,160 (83%)\n\n\n30,110 (77%)\n\n\nCharlson comorbidity index\n3.50 (1.94)\n3.76 (1.95)\n&lt;0.001\n3.64 (1.95)\n\n\nDiabetes Mellitus\n6,860 (37%)\n8,540 (41%)\n&lt;0.001\n15,400 (39%)\n\n\nPrevious myocardial infarction\n3,305 (18%)\n3,300 (16%)\n0.038\n6,605 (17%)\n\n\nobesity\n5,085 (27%)\n6,350 (31%)\n&lt;0.001\n11,435 (29%)\n\n\nHypertension\n9,560 (51%)\n9,050 (44%)\n&lt;0.001\n18,610 (47%)\n\n\nPulmonary Hypertension\n2,570 (14%)\n4,300 (21%)\n&lt;0.001\n6,870 (17%)\n\n\nChronic obstructive pulmonary disease\n5,095 (27%)\n6,880 (33%)\n&lt;0.001\n11,975 (30%)\n\n\nAlcohol use\n7,170 (38%)\n8,625 (42%)\n0.004\n15,795 (40%)\n\n\nPeripheral vascular disease\n1,300 (7.0%)\n1,415 (6.8%)\n0.8\n2,715 (6.9%)\n\n\nAnemia\n1,050 (5.6%)\n1,450 (7.0%)\n0.009\n2,500 (6.4%)\n\n\nPrevious PCI\n2,770 (15%)\n2,650 (13%)\n0.010\n5,420 (14%)\n\n\nValvular heart disease\n5,415 (29%)\n7,195 (35%)\n&lt;0.001\n12,610 (32%)\n\n\nObstructive sleep apnea\n4,640 (25%)\n5,220 (25%)\n0.7\n9,860 (25%)\n\n\nCoronary artery disease\n10,165 (54%)\n10,965 (53%)\n0.2\n21,130 (54%)\n\n\nEnd stage renal disease\n920 (4.9%)\n695 (3.4%)\n&lt;0.001\n1,615 (4.1%)\n\n\nPrevious CABG\n2,535 (14%)\n2,860 (14%)\n0.7\n5,395 (14%)\n\n\nHyperthyroidism\n315 (1.7%)\n375 (1.8%)\n0.7\n690 (1.8%)\n\n\nPrevious stroke/TIA\n2,445 (13%)\n2,170 (10%)\n&lt;0.001\n4,615 (12%)\n\n\nPrevious ICD insertion\n4,250 (23%)\n3,050 (15%)\n&lt;0.001\n7,300 (19%)\n\n\nPrevious PPM or CRT insertion\n1,645 (8.8%)\n1,845 (8.9%)\n0.9\n3,490 (8.9%)\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Impact of Catheter Ablation in Atrial Fibrillation Among Patients with Heart Failure with Reduced Versus Preserved Ejection Fraction",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nAtrial fibrillation with heart failure reduced ejection fraction\nN = 18,6851\nAtrial fibrillation with heart failure preserved ejection fraction\nN = 20,6751\np-value2\nOverall\nN = 39,3601\n\n\n\n\nDied during hospitalization\n235 (1.3%)\n450 (2.2%)\n0.003\n685 (1.7%)\n\n\nLength of stay (days)\n4 (2, 7)\n7 (4, 11)\n&lt;0.001\n5 (3, 9)\n\n\nInflation-adjusted total charge ($)\n145,714 (99,661, 222,431)\n167,630 (108,164, 257,971)\n&lt;0.001\n156,923 (103,881, 240,706)\n\n\nAcute kidney injury\n4,325 (23%)\n8,870 (43%)\n&lt;0.001\n13,195 (34%)\n\n\nAcute ischemic stroke\n215 (1.2%)\n185 (0.9%)\n0.3\n400 (1.0%)\n\n\nAcute myocardial infarction\n975 (5.2%)\n1,500 (7.3%)\n&lt;0.001\n2,475 (6.3%)\n\n\nCardiac tamponade\n160 (0.9%)\n145 (0.7%)\n0.4\n305 (0.8%)\n\n\nCardiac arrest\n285 (1.5%)\n400 (1.9%)\n0.2\n685 (1.7%)\n\n\nCardiogenic shock\n885 (4.7%)\n1,965 (9.5%)\n&lt;0.001\n2,850 (7.2%)\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Impact of Catheter Ablation in Atrial Fibrillation Among Patients with Heart Failure with Reduced Versus Preserved Ejection Fraction",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Atrial fibrillation with heart failure reduced ejection fraction\n—\n—\n\n\n\n\n    Atrial fibrillation with heart failure preserved ejection fraction\n1.66\n1.12, 2.46\n0.012\n\n\nAge, y\n1.02\n1.00, 1.04\n0.075\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.47\n0.98, 2.19\n0.063\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.53\n0.07, 3.73\n0.5\n\n\n    Black\n0.91\n0.51, 1.61\n0.7\n\n\n    Hispanic\n0.75\n0.28, 2.04\n0.6\n\n\n    Native American\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Other\n1.92\n0.81, 4.55\n0.14\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.85\n0.52, 1.38\n0.5\n\n\n    $66,000 - $87,999\n0.86\n0.52, 1.42\n0.6\n\n\n    $88,000 or more\n0.76\n0.43, 1.34\n0.3\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.79\n0.32, 1.97\n0.6\n\n\n    Medicare\n0.82\n0.47, 1.42\n0.5\n\n\n    Other\n2.06\n0.95, 4.47\n0.069\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.08\n0.61, 1.91\n0.8\n\n\n    South\n0.97\n0.60, 1.58\n&gt;0.9\n\n\n    West\n1.10\n0.60, 2.00\n0.8\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.66\n0.40, 1.07\n0.091\n\n\n    Small\n0.65\n0.35, 1.21\n0.2\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.32\n0.27, 6.52\n0.7\n\n\n    Urban, teaching\n1.94\n0.47, 8.08\n0.4\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n1.36\n0.84, 2.22\n0.2\n\n\nCharlson comorbidity index\n1.11\n0.94, 1.30\n0.2\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.72\n0.43, 1.21\n0.2\n\n\nPulmonary Hypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.99\n1.34, 2.97\n&lt;0.001\n\n\nHyperthyroidism\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.42\n0.06, 3.15\n0.4\n\n\nPrevious myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.54, 1.57\n0.8\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.48\n0.29, 0.81\n0.006\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.25\n0.83, 1.88\n0.3\n\n\nAlcohol use\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.99\n0.69, 1.43\n&gt;0.9\n\n\nobesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.54\n0.34, 0.87\n0.011\n\n\nEnd stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.21\n1.22, 3.98\n0.009\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.61, 1.47\n0.8\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.51, 1.88\n&gt;0.9\n\n\nPrevious PCI\n0.93\n0.51, 1.70\n0.8\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.77\n0.45, 1.33\n0.4\n\n\nPrevious ICD insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.19\n0.78, 1.82\n0.4\n\n\nPrevious PPM or CRT insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.73\n0.35, 1.51\n0.4\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.56, 1.22\n0.3\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.44\n0.22, 0.91\n0.026\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.45\n0.81, 2.59\n0.2\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.64\n0.42, 0.96\n0.032\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nAcute Kidney Injury\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Atrial fibrillation with heart failure reduced ejection fraction\n—\n—\n\n\n\n\n    Atrial fibrillation with heart failure preserved ejection fraction\n2.17\n1.94, 2.43\n&lt;0.001\n\n\nAge, y\n1.00\n1.00, 1.01\n0.3\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.44\n1.27, 1.63\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.67\n1.12, 2.49\n0.012\n\n\n    Black\n1.32\n1.12, 1.56\n0.001\n\n\n    Hispanic\n1.12\n0.89, 1.42\n0.3\n\n\n    Native American\n1.19\n0.50, 2.85\n0.7\n\n\n    Other\n1.55\n1.07, 2.24\n0.020\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.94\n0.81, 1.08\n0.4\n\n\n    $66,000 - $87,999\n1.04\n0.89, 1.21\n0.7\n\n\n    $88,000 or more\n1.01\n0.86, 1.18\n&gt;0.9\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.07\n0.84, 1.37\n0.6\n\n\n    Medicare\n1.05\n0.89, 1.24\n0.6\n\n\n    Other\n1.22\n0.91, 1.65\n0.2\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.78\n0.66, 0.93\n0.006\n\n\n    South\n0.87\n0.76, 1.00\n0.059\n\n\n    West\n0.95\n0.80, 1.14\n0.6\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.90\n0.79, 1.03\n0.14\n\n\n    Small\n0.93\n0.77, 1.11\n0.4\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.36\n0.87, 2.10\n0.2\n\n\n    Urban, teaching\n1.45\n0.96, 2.17\n0.075\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n1.81\n1.58, 2.07\n&lt;0.001\n\n\nCharlson comorbidity index\n1.22\n1.16, 1.27\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.79, 1.05\n0.2\n\n\nPulmonary Hypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.31\n1.13, 1.51\n&lt;0.001\n\n\nHyperthyroidism\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.86\n0.55, 1.32\n0.5\n\n\nPrevious myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.73\n0.62, 0.86\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.34\n0.29, 0.39\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.87\n0.77, 0.99\n0.029\n\n\nAlcohol use\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.89, 1.12\n&gt;0.9\n\n\nobesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.12\n0.99, 1.26\n0.077\n\n\nEnd stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.14\n0.10, 0.19\n&lt;0.001\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.80, 1.03\n0.14\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.25\n1.02, 1.54\n0.035\n\n\nPrevious PCI\n0.84\n0.70, 1.00\n0.047\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.70, 0.98\n0.030\n\n\nPrevious ICD insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.72\n0.62, 0.84\n&lt;0.001\n\n\nPrevious PPM or CRT insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.76\n0.63, 0.93\n0.008\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.05\n0.92, 1.18\n0.5\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.87\n0.72, 1.03\n0.11\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.78, 1.20\n0.8\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.07\n0.95, 1.20\n0.3\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nAcute Ischemic Stroke\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Atrial fibrillation with heart failure reduced ejection fraction\n—\n—\n\n\n\n\n    Atrial fibrillation with heart failure preserved ejection fraction\n0.80\n0.48, 1.34\n0.4\n\n\nAge, y\n1.01\n0.98, 1.03\n0.7\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.03\n0.60, 1.75\n&gt;0.9\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.05\n0.17, 6.38\n&gt;0.9\n\n\n    Black\n0.92\n0.43, 1.95\n0.8\n\n\n    Hispanic\n1.39\n0.59, 3.29\n0.4\n\n\n    Native American\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Other\n2.18\n0.70, 6.82\n0.2\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.15\n0.62, 2.14\n0.7\n\n\n    $66,000 - $87,999\n1.01\n0.52, 1.97\n&gt;0.9\n\n\n    $88,000 or more\n0.73\n0.33, 1.60\n0.4\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.16\n0.46, 2.95\n0.8\n\n\n    Medicare\n0.57\n0.28, 1.15\n0.12\n\n\n    Other\n0.46\n0.09, 2.30\n0.3\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.90\n0.39, 2.06\n0.8\n\n\n    South\n0.98\n0.50, 1.92\n&gt;0.9\n\n\n    West\n1.70\n0.75, 3.83\n0.2\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.64\n0.34, 1.22\n0.2\n\n\n    Small\n0.96\n0.42, 2.19\n&gt;0.9\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.73\n0.19, 2.89\n0.7\n\n\n    Urban, teaching\n0.58\n0.17, 1.98\n0.4\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n0.81\n0.45, 1.47\n0.5\n\n\nCharlson comorbidity index\n1.83\n1.62, 2.06\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.38\n0.22, 0.66\n&lt;0.001\n\n\nPulmonary Hypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.86\n0.42, 1.75\n0.7\n\n\nHyperthyroidism\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.58\n0.07, 5.13\n0.6\n\n\nPrevious myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.49\n0.24, 0.99\n0.046\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.28\n1.26, 4.11\n0.006\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.34\n0.18, 0.66\n0.001\n\n\nAlcohol use\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.90\n0.54, 1.51\n0.7\n\n\nobesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.90\n0.51, 1.59\n0.7\n\n\nEnd stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.33\n0.07, 1.66\n0.2\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.74\n0.40, 1.36\n0.3\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.26\n0.55, 2.89\n0.6\n\n\nPrevious PCI\n0.73\n0.33, 1.61\n0.4\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.55\n0.23, 1.34\n0.2\n\n\nPrevious ICD insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.38\n0.18, 0.81\n0.013\n\n\nPrevious PPM or CRT insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.60\n0.21, 1.68\n0.3\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.45\n0.87, 2.41\n0.2\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.16\n0.55, 2.43\n0.7\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.21\n0.05, 0.91\n0.037\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.67\n0.38, 1.19\n0.2\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nAcute Myocardial Infarction\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Atrial fibrillation with heart failure reduced ejection fraction\n—\n—\n\n\n\n\n    Atrial fibrillation with heart failure preserved ejection fraction\n1.24\n1.01, 1.53\n0.039\n\n\nAge, y\n1.00\n0.99, 1.01\n0.5\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.02\n0.81, 1.27\n0.9\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.03\n0.48, 2.22\n&gt;0.9\n\n\n    Black\n0.75\n0.55, 1.04\n0.083\n\n\n    Hispanic\n1.47\n1.02, 2.11\n0.037\n\n\n    Native American\n0.55\n0.06, 4.76\n0.6\n\n\n    Other\n1.23\n0.63, 2.37\n0.5\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.86\n0.65, 1.14\n0.3\n\n\n    $66,000 - $87,999\n0.86\n0.65, 1.14\n0.3\n\n\n    $88,000 or more\n0.86\n0.63, 1.18\n0.4\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.62\n1.06, 2.47\n0.027\n\n\n    Medicare\n0.93\n0.68, 1.28\n0.7\n\n\n    Other\n1.35\n0.79, 2.31\n0.3\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.89\n0.63, 1.25\n0.5\n\n\n    South\n0.88\n0.68, 1.14\n0.3\n\n\n    West\n1.02\n0.74, 1.41\n0.9\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.99\n0.78, 1.26\n&gt;0.9\n\n\n    Small\n1.16\n0.86, 1.57\n0.3\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.82\n0.42, 1.61\n0.6\n\n\n    Urban, teaching\n1.04\n0.58, 1.90\n0.9\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n4.44\n2.96, 6.65\n&lt;0.001\n\n\nCharlson comorbidity index\n1.55\n1.46, 1.65\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.61\n0.48, 0.78\n&lt;0.001\n\n\nPulmonary Hypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.30\n1.01, 1.66\n0.042\n\n\nHyperthyroidism\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.28\n0.08, 0.97\n0.045\n\n\nPrevious myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.63, 1.08\n0.2\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.89\n1.49, 2.40\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.45\n0.35, 0.57\n&lt;0.001\n\n\nAlcohol use\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.81, 1.23\n&gt;0.9\n\n\nobesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.05\n0.83, 1.32\n0.7\n\n\nEnd stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.42\n0.95, 2.14\n0.089\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.65, 1.06\n0.14\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.67, 1.43\n0.9\n\n\nPrevious PCI\n0.99\n0.75, 1.31\n&gt;0.9\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.90\n0.66, 1.21\n0.5\n\n\nPrevious ICD insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.55\n0.42, 0.73\n&lt;0.001\n\n\nPrevious PPM or CRT insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.61\n0.41, 0.89\n0.011\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.07\n1.63, 2.64\n&lt;0.001\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.70, 1.28\n0.7\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.62\n0.42, 0.93\n0.021\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.76, 1.15\n0.5\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nCardiac Tamponade\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Atrial fibrillation with heart failure reduced ejection fraction\n—\n—\n\n\n\n\n    Atrial fibrillation with heart failure preserved ejection fraction\n1.11\n0.64, 1.94\n0.7\n\n\nAge, y\n1.00\n0.98, 1.03\n0.8\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.74\n0.43, 1.28\n0.3\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n3.55\n0.79, 15.9\n0.10\n\n\n    Black\n0.32\n0.08, 1.22\n0.094\n\n\n    Hispanic\n0.31\n0.04, 2.52\n0.3\n\n\n    Native American\n3.71\n0.37, 36.7\n0.3\n\n\n    Other\n0.84\n0.13, 5.40\n0.8\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.96\n0.75, 5.14\n0.2\n\n\n    $66,000 - $87,999\n3.55\n1.45, 8.67\n0.005\n\n\n    $88,000 or more\n1.82\n0.68, 4.93\n0.2\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.44\n0.05, 3.76\n0.5\n\n\n    Medicare\n1.69\n0.66, 4.34\n0.3\n\n\n    Other\n2.37\n0.61, 9.23\n0.2\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.02\n0.42, 2.48\n&gt;0.9\n\n\n    South\n1.42\n0.70, 2.89\n0.3\n\n\n    West\n1.35\n0.58, 3.16\n0.5\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.82\n0.42, 1.60\n0.6\n\n\n    Small\n0.43\n0.14, 1.33\n0.14\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.20\n0.03, 1.15\n0.071\n\n\n    Urban, teaching\n0.47\n0.13, 1.76\n0.3\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n0.29\n0.17, 0.49\n&lt;0.001\n\n\nCharlson comorbidity index\n0.81\n0.61, 1.08\n0.2\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.39, 1.82\n0.7\n\n\nPulmonary Hypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.39, 1.76\n0.6\n\n\nHyperthyroidism\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.77\n0.67, 11.4\n0.2\n\n\nPrevious myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.39, 2.33\n&gt;0.9\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.69\n0.34, 1.39\n0.3\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.22\n0.60, 2.49\n0.6\n\n\nAlcohol use\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.44, 1.41\n0.4\n\n\nobesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.06\n0.56, 2.02\n0.9\n\n\nEnd stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.55\n0.34, 7.07\n0.6\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.27\n0.68, 2.38\n0.5\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.98\n0.81, 4.81\n0.13\n\n\nPrevious PCI\n1.94\n0.91, 4.11\n0.085\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nPrevious ICD insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.05\n0.54, 2.06\n0.9\n\n\nPrevious PPM or CRT insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.71\n0.25, 2.07\n0.5\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.14\n0.62, 2.09\n0.7\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.60\n0.21, 1.73\n0.3\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.04\n0.33, 3.30\n&gt;0.9\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.57\n0.31, 1.07\n0.082\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nCardiac Arrest\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Atrial fibrillation with heart failure reduced ejection fraction\n—\n—\n\n\n\n\n    Atrial fibrillation with heart failure preserved ejection fraction\n1.33\n0.90, 1.95\n0.2\n\n\nAge, y\n0.98\n0.96, 1.00\n0.11\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.09\n0.73, 1.64\n0.7\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Black\n1.06\n0.62, 1.80\n0.8\n\n\n    Hispanic\n2.03\n1.15, 3.60\n0.015\n\n\n    Native American\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Other\n2.05\n0.80, 5.23\n0.14\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.27\n0.77, 2.09\n0.4\n\n\n    $66,000 - $87,999\n1.50\n0.90, 2.52\n0.12\n\n\n    $88,000 or more\n1.38\n0.80, 2.40\n0.2\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.55\n0.24, 1.23\n0.15\n\n\n    Medicare\n0.91\n0.56, 1.50\n0.7\n\n\n    Other\n0.67\n0.26, 1.76\n0.4\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.71\n0.40, 1.25\n0.2\n\n\n    South\n0.79\n0.51, 1.22\n0.3\n\n\n    West\n0.74\n0.40, 1.37\n0.3\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.19\n0.79, 1.79\n0.4\n\n\n    Small\n1.14\n0.64, 2.04\n0.6\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.25\n0.27, 5.82\n0.8\n\n\n    Urban, teaching\n1.29\n0.31, 5.35\n0.7\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n0.84\n0.56, 1.27\n0.4\n\n\nCharlson comorbidity index\n1.07\n0.91, 1.26\n0.4\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.65, 1.52\n&gt;0.9\n\n\nPulmonary Hypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.03\n0.67, 1.60\n0.9\n\n\nHyperthyroidism\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nPrevious myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.52\n0.95, 2.44\n0.078\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.03\n0.64, 1.67\n&gt;0.9\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.70\n0.46, 1.05\n0.082\n\n\nAlcohol use\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.16\n0.79, 1.68\n0.5\n\n\nobesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.60, 1.28\n0.5\n\n\nEnd stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.74\n0.87, 3.49\n0.12\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.01\n0.66, 1.54\n&gt;0.9\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.37, 1.70\n0.6\n\n\nPrevious PCI\n0.91\n0.52, 1.58\n0.7\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.66\n0.35, 1.25\n0.2\n\n\nPrevious ICD insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.49, 1.30\n0.4\n\n\nPrevious PPM or CRT insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.35\n0.12, 0.96\n0.042\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.55, 1.28\n0.4\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.48\n0.23, 1.01\n0.053\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.07\n0.51, 2.25\n0.8\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.16\n0.78, 1.73\n0.5\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nCardiogenic Shock\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Atrial fibrillation with heart failure reduced ejection fraction\n—\n—\n\n\n\n\n    Atrial fibrillation with heart failure preserved ejection fraction\n2.08\n1.72, 2.52\n&lt;0.001\n\n\nAge, y\n0.98\n0.97, 0.99\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.62\n1.31, 2.02\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.43\n0.75, 2.72\n0.3\n\n\n    Black\n0.92\n0.70, 1.21\n0.5\n\n\n    Hispanic\n1.16\n0.80, 1.70\n0.4\n\n\n    Native American\n1.32\n0.42, 4.13\n0.6\n\n\n    Other\n1.38\n0.78, 2.47\n0.3\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.90\n0.70, 1.17\n0.4\n\n\n    $66,000 - $87,999\n0.81\n0.62, 1.05\n0.11\n\n\n    $88,000 or more\n0.83\n0.63, 1.10\n0.2\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.73\n0.49, 1.08\n0.11\n\n\n    Medicare\n1.11\n0.85, 1.45\n0.5\n\n\n    Other\n0.77\n0.46, 1.28\n0.3\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.69\n0.50, 0.95\n0.024\n\n\n    South\n0.84\n0.65, 1.09\n0.2\n\n\n    West\n1.20\n0.89, 1.62\n0.2\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.68\n0.54, 0.86\n0.001\n\n\n    Small\n0.70\n0.51, 0.96\n0.027\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.26\n0.61, 2.63\n0.5\n\n\n    Urban, teaching\n2.23\n1.16, 4.29\n0.016\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n1.51\n1.17, 1.96\n0.002\n\n\nCharlson comorbidity index\n1.03\n0.95, 1.11\n0.5\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.09\n0.85, 1.40\n0.5\n\n\nPulmonary Hypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.59\n1.29, 1.98\n&lt;0.001\n\n\nHyperthyroidism\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.43, 1.63\n0.6\n\n\nPrevious myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.70, 1.21\n0.5\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.48\n0.38, 0.61\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.66\n0.52, 0.83\n&lt;0.001\n\n\nAlcohol use\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.01\n0.83, 1.23\n&gt;0.9\n\n\nobesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.58\n0.46, 0.73\n&lt;0.001\n\n\nEnd stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.60\n0.37, 0.99\n0.044\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.82\n0.66, 1.02\n0.079\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.61\n1.17, 2.23\n0.004\n\n\nPrevious PCI\n0.79\n0.58, 1.07\n0.13\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.60, 1.07\n0.13\n\n\nPrevious ICD insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.14\n0.88, 1.46\n0.3\n\n\nPrevious PPM or CRT insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.74\n0.51, 1.08\n0.12\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.13\n0.92, 1.38\n0.2\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.62\n0.45, 0.86\n0.004\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.10\n0.77, 1.55\n0.6\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.15\n0.96, 1.38\n0.13\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Impact of Catheter Ablation in Atrial Fibrillation Among Patients with Heart Failure with Reduced Versus Preserved Ejection Fraction",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Atrial fibrillation with heart failure reduced ejection fraction\n—\n—\n\n\n\n\n    Atrial fibrillation with heart failure preserved ejection fraction\n2.5\n2.1, 2.8\n&lt;0.001\n\n\nAge, y\n-0.03\n-0.05, 0.00\n0.016\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.62\n0.24, 0.99\n0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.5\n-0.80, 3.8\n0.2\n\n\n    Black\n0.84\n0.14, 1.5\n0.018\n\n\n    Hispanic\n0.21\n-0.52, 0.95\n0.6\n\n\n    Native American\n-0.01\n-1.7, 1.7\n&gt;0.9\n\n\n    Other\n0.92\n-0.30, 2.1\n0.14\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.14\n-0.59, 0.30\n0.5\n\n\n    $66,000 - $87,999\n-0.29\n-0.83, 0.25\n0.3\n\n\n    $88,000 or more\n-0.19\n-0.70, 0.32\n0.5\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-0.31\n-1.2, 0.57\n0.5\n\n\n    Medicare\n-0.11\n-0.67, 0.44\n0.7\n\n\n    Other\n-1.2\n-1.9, -0.41\n0.003\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.06\n-0.50, 0.62\n0.8\n\n\n    South\n0.04\n-0.40, 0.48\n0.9\n\n\n    West\n-0.04\n-0.68, 0.59\n0.9\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.93\n-1.3, -0.55\n&lt;0.001\n\n\n    Small\n-1.2\n-1.6, -0.70\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n-0.14\n-1.2, 0.90\n0.8\n\n\n    Urban, teaching\n0.63\n-0.32, 1.6\n0.2\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n2.5\n2.1, 2.9\n&lt;0.001\n\n\nCharlson comorbidity index\n0.36\n0.22, 0.51\n&lt;0.001\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.45\n-0.90, 0.00\n0.051\n\n\nPulmonary Hypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.7\n1.2, 2.3\n&lt;0.001\n\n\nHyperthyroidism\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.58\n-0.57, 1.7\n0.3\n\n\nPrevious myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.88\n-1.3, -0.47\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.86\n-1.3, -0.44\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.69\n0.28, 1.1\n&lt;0.001\n\n\nAlcohol use\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.18\n-0.57, 0.20\n0.3\n\n\nobesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.07\n-0.51, 0.37\n0.8\n\n\nEnd stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.0\n0.33, 3.6\n0.019\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.62\n-1.0, -0.22\n0.002\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.0\n0.92, 3.1\n&lt;0.001\n\n\nPrevious PCI\n-0.57\n-0.95, -0.18\n0.004\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.90\n-1.3, -0.53\n&lt;0.001\n\n\nPrevious ICD insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.93\n-1.5, -0.40\n&lt;0.001\n\n\nPrevious PPM or CRT insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.1\n-1.5, -0.68\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.17\n-0.59, 0.25\n0.4\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.80\n-1.2, -0.39\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.42\n-0.22, 1.1\n0.2\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.12\n-0.26, 0.49\n0.5\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Atrial fibrillation with heart failure reduced ejection fraction\n—\n—\n\n\n\n\n    Atrial fibrillation with heart failure preserved ejection fraction\n27,858\n18,564, 37,152\n&lt;0.001\n\n\nAge, y\n-1,132\n-1,639, -625\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n29,254\n20,489, 38,020\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n73,562\n15,395, 131,730\n0.013\n\n\n    Black\n13,047\n-4,192, 30,285\n0.14\n\n\n    Hispanic\n34,853\n13,894, 55,813\n0.001\n\n\n    Native American\n35,870\n-48,303, 120,044\n0.4\n\n\n    Other\n64,168\n17,589, 110,748\n0.007\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1,749\n-9,973, 13,471\n0.8\n\n\n    $66,000 - $87,999\n4,288\n-8,994, 17,569\n0.5\n\n\n    $88,000 or more\n11,504\n-3,209, 26,217\n0.13\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-30,244\n-51,754, -8,735\n0.006\n\n\n    Medicare\n-5,574\n-21,144, 9,996\n0.5\n\n\n    Other\n-14,913\n-37,429, 7,603\n0.2\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n44,110\n25,628, 62,592\n&lt;0.001\n\n\n    South\n43,560\n32,224, 54,896\n&lt;0.001\n\n\n    West\n74,583\n53,765, 95,401\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-13,331\n-25,930, -731\n0.038\n\n\n    Small\n-1,577\n-19,665, 16,511\n0.9\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n50,044\n22,037, 78,052\n&lt;0.001\n\n\n    Urban, teaching\n53,665\n28,135, 79,194\n&lt;0.001\n\n\nAdmission type\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n-1,949\n-12,422, 8,523\n0.7\n\n\nCharlson comorbidity index\n2,378\n-1,404, 6,160\n0.2\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-5,844\n-17,380, 5,692\n0.3\n\n\nPulmonary Hypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n14,045\n2,091, 25,999\n0.021\n\n\nHyperthyroidism\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-8,874\n-31,433, 13,685\n0.4\n\n\nPrevious myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-12,651\n-23,687, -1,614\n0.025\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-17,944\n-29,863, -6,026\n0.003\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5,535\n-4,576, 15,645\n0.3\n\n\nAlcohol use\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n13,187\n1,415, 24,959\n0.028\n\n\nobesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n330\n-9,753, 10,412\n&gt;0.9\n\n\nEnd stage renal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n18,971\n-13,068, 51,010\n0.2\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,706\n-21,114, -298\n0.044\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n22,298\n3,264, 41,332\n0.022\n\n\nPrevious PCI\n-13,449\n-23,244, -3,655\n0.007\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,969\n-21,589, -348\n0.043\n\n\nPrevious ICD insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-21,793\n-34,434, -9,152\n&lt;0.001\n\n\nPrevious PPM or CRT insertion\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-47,539\n-57,210, -37,868\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n9,349\n-734, 19,432\n0.069\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-15,220\n-25,887, -4,552\n0.005\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n10,587\n-4,844, 26,018\n0.2\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n203\n-8,913, 9,319\n&gt;0.9\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]